Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.

MLA

Arevalo-Perez, Julio, et al. “Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.” Cancers, vol. 16, no. 10, May 2024, p. 1839. EBSCOhost, https://doi.org/10.3390/cancers16101839.

APA

Arevalo-Perez, J., Trang, A., Yllera-Contreras, E., Yildirim, O., Saha, A., Young, R., Lyo, J., Peck, K. K., & Holodny, A. I. (2024). Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma. Cancers, 16(10), 1839. https://doi.org/10.3390/cancers16101839

Chicago

Arevalo-Perez, Julio, Andy Trang, Elena Yllera-Contreras, Onur Yildirim, Atin Saha, Robert Young, John Lyo, Kyung K. Peck, and Andrei I. Holodny. 2024. “Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.” Cancers 16 (10): 1839. doi:10.3390/cancers16101839.